Note: We encourage you to share your feedback, contributions and suggestions to
About MedGenome Labs |
|---|
|
MedGenome is a genomics and clinical data driven diagnostics and drug discovery research company founded in 2013. MedGenome is the market leader in genetic diagnostics in India and one of the highest throughput NGS sequencing lab in South Asia. We possess state-of-the-art Next Generation Sequencing (NGS) facility housing cutting-edge genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X , HiSeq 4000 and 2500, MiSeq, etc. Our Sequencing facility is supported by a sophisticated IHC pathology lab and we even utilize modern molecular techniques such as FISH, PCR, Sanger Sequencing and Microarray to offer comprehensive diagnostic solutions to researchers, doctors and hospitals. We currently offer more than 475 genetic tests across several disease categories such as paediatrics, neurology, oncology, hematology, endocrinology, nephrology, ophthalmology, etc. Our footprint covers the whole of India and parts of South Asia with over 550 hospitals and more than 5,500 clinicians leveraging our services. MedGenome has successfully partnered with major hospitals and research centres across India. We have setup Genome Centres in key cities across India to create awareness about the utility and efficacy of genetic testing in a clinic and offer services that are relevant and affordable to patients to manage their health outcomes. Innovation is a core belief and many of our tests have been developed in-house including our comprehensive Gene Panels. Our liquid biopsy test OncoTrack for monitoring cancer treatment is the only NGS-based ctDNA test available in India. We even offer carrier screening test for couples planning a baby and whole exome sequencing test for identifying gene mutations in rare diseases. We believe in continuous innovation to help reduce the cost of genetic tests and empower clinicians with actionable clinical insights to provide better outcomes. As a firm believer in quality, MedGenome adheres to the highest international standards when it comes to our services and have obtained the prestigious CAP accreditation for all our Labs across India. Our business has grown two-fold in the past 3 years and now we also offer diagnostics services in South Asia, Middle East, Eastern Europe and Africa. Our expert scientific team, data scientists and bioinformaticians fuel our genomics research and we have successfully built research pipelines addressing immuno-oncology, biomarker discovery, companion diagnostics and population-based genomic studies that taps the rich Indian diverse genotype. We have worked extensively on building clinical databases of more than 1 million patients through collaborations. We have a repository of clinical, phenotypic and genomics data for 170,000 patients to provide insights into complex diseases at genetic and molecular level. Since the company works extensively in the Indian sub-continent, we have access to data that provides insights into genetic diversity of Indian population for more than 4,500 population groups. Over the years we have also focussed on building tools and IP that could be leveraged by researchers and pharmaceutical companies to aid in drug discovery and clinical trial. These tools cover disease segments such as oncology, diabetes, ophthalmology, cardiology and other rare diseases. MedGenome is a founding member of GenomeAsia 100K, an initiative to sequence 100,000 Genomes in Asia, which would enable us to provide a unique resource of genetic research for the world. Headquartered in California, USA we have a workforce of more than 450 people across the globe with offices in Bangalore, Kochi, Mumbai, Delhi, Chennai and Singapore. |
